• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Atherosclerosis is a chronic inflammatory disease, in which the immune system has a
prominent role in its development and progression. Inflammation-induced endothelial …

2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …

Background In patients with acute coronary syndrome and multivessel coronary disease,
complete revascularisation by percutaneous coronary intervention (PCI) is associated with …

Aims In patients with acute myocardial infarction (MI) and multivessel coronary artery
disease, percutaneous coronary intervention (PCI) of non-infarct-related artery reduces …

comprehensive review of the published evidence for management of a given condition
according to ESC Committee for Practice Guidelines (CPG) policy. A critical evaluation of …

Coronary artery disease is the leading cause of morbidity and mortality worldwide. Selected
patients with obstructive coronary artery disease benefit from revascularization with …

Importance Even after fractional flow reserve (FFR)–guided complete revascularization,
patients with myocardial infarction (MI) have high rates of recurrent major adverse …

Introduction The randomized, double-blind phase (DBP) of the TOLEDO study confirmed the
efficacy of apomorphine infusion (APO) in reducing OFF time in PD patients with persistent …

Abstract Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to
reducing the mortality of patients with ST-segment elevation myocardial infarction (STEMI) …